ArticleHealth science reports2026
The Effect of Gestational Diabetes on Neonatal Outcomes in Jeddah City: A Retrospective Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The prevalence of gestational diabetes mellitus (GDM) in Saudi Arabia is believed to affect 36% of all pregnant women. Many adverse outcomes affect the lives of the neonates of these mothers. Therefore, this study aims to assess the association between GDM and neonatal health outcomes in Jeddah City, Saudi Arabia. Methods: A retrospective cohort design was used. Two hundred neonatal records were reviewed: 100 for neonates of mothers who had GDM and 100 without GDM for control. The two groups were compared in terms of neonatal outcomes. Results: The gestational age and the glycemic level of neonates of mothers without GDM were significantly higher than those with GDM (39± weeks vs. 37 weeks and 63± vs. 55 mg/dL, Conclusion: This study provides empirical evidence demonstrating the negative effect of GDM on neonatal health outcomes, mainly in terms of hypoglycemia, respiratory distress syndrome, and congenital anomalies. Therefore, it highlights the importance of adequate glycemic control by specifying proper treatment together with dietary intervention and exercise programs to improve outcomes. All authors have read and approved the final version of the manuscript. Corresponding author had full access to all the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.